Search results
Peter Illes
Job title: Interventional Cardiologist
Author
HRS 2018: MARVEL Study
Author(s):
Larry Chinitz
Added:
5 years ago
Video
Author(s):
Saagar Mahida
,
Frédéric Sacher
,
Nicolas Derval
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice. The discovery that pulmonary veins (PV) play a prominent role in the pathogenesis of AF has revolutionised the management of AF. PV isolation has become the most widely used technique for treatment of paroxysmal AF. Since the initial discovery implicating PVs in AF pathogenesis, the mechanistic link between…
View more
Francis E Marchlinski
Research Area(s) / Expertise:
Job title: Director of Electrophysiology Laboratory
Author
Author(s):
Thorsten Lewalter
,
Giuseppe Boriani
Added:
3 years ago
The monitoring of atrial fibrillation (AF) can be performed using a great variety of strategies and tools. Strategies range from monitoring only symptomatic AF (e.g., post-catheter ablation with or without surface electrocardiogram [ECG] documentation) to continuously monitoring heart rhythm using implantable pacemakers, implantable cardioverter defibrillators (ICDs) or subcutaneous implantable…
View more
Mathias Meine
Author
Author(s):
Melani Sotiriadou
,
Antonios P Antoniadis
,
Nikolaos Fragakis
,
et al
Added:
2 years ago
Author(s):
Adryan A Perez
,
Frank W Woo
,
Darren C Tsang
,
et al
Added:
3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia…
View more
Author(s):
Mads Brix Kronborg
Added:
7 months ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158).
DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40…
View more
Christoph Hammerstingl
Job title: Head of the department of Internal Medicine and Cardiology
Author